We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
-4.71%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$109B
AUM Growth
+$10.3B
Cap. Flow
+$17.5B
Cap. Flow %
16%
Top 10 Hldgs %
37.15%
Holding
12,038
New
1,603
Increased
4,441
Reduced
4,088
Closed
1,637

Sector Composition

Rank Sector Weight
1 Technology 0.67%
2 Consumer Discretionary 0.37%
3 Industrials 0.24%
4 Healthcare 0.22%
5 Financials 0.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTCH
9976
PUT
DELISTED
Latch, Inc. Common Stock
LTCH
$2K ﹤0.01%
700
-12,100
-95% -$63.3K
NOVN
9977
DELISTED
Novan, Inc. Common Stock
NOVN
$2K ﹤0.01%
591
-1,592
-73% -$5.86K
SGTX
9978
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$2K ﹤0.01%
143
+100
+233% +$2.23K
SGTX
9979
PUT
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$2K ﹤0.01%
146
+77
+112% +$1.72K
VNTR
9980
PUT
DELISTED
Venator Materials PLC
VNTR
$2K ﹤0.01%
1,600
-1,800
-53% -$4.01K
AGRX
9981
CALL
DELISTED
Agile Therapeutics
AGRX
$2K ﹤0.01%
7
-3
-30% -$1.92K
AGFS
9982
DELISTED
AgroFresh Solutions Inc
AGFS
$2K ﹤0.01%
1,192
+407
+52% +$819
FCRD
9983
CALL
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$2K ﹤0.01%
+600
New +$2.67K
KNBE
9984
PUT
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
$2K ﹤0.01%
100
-4,600
-98% -$98.7K
BTRS
9985
CALL
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$2K ﹤0.01%
400
-5,000
-93% -$32.4K
ELOX
9986
PUT
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$2K ﹤0.01%
125
-1,160
-90% -$22.8K
EQOS
9987
PUT
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$2K ﹤0.01%
1,100
-13,900
-93% -$26.4K
JGLD
9988
DELISTED
Amplify Pure Junior Gold Miners ETF
JGLD
$2K ﹤0.01%
+100
New +$2.32K
NBEV
9989
CALL
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$2K ﹤0.01%
3,900
-3,900
-50% -$2.79K
EPZM
9990
PUT
DELISTED
Epizyme, Inc
EPZM
$2K ﹤0.01%
2,100
+1,700
+425% +$2.77K
MILE
9991
CALL
DELISTED
Metromile, Inc. Common Stock
MILE
$2K ﹤0.01%
+1,900
New +$2.75K
EVFM
9992
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$2K ﹤0.01%
533
VOLT
9993
DELISTED
Volt Information Sciences, Inc.
VOLT
$2K ﹤0.01%
366
-1,246
-77% -$4.73K
KLDO
9994
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$2K ﹤0.01%
+1,268
New +$2.26K
TLMD
9995
PUT
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$2K ﹤0.01%
24,100
+13,000
+117% +$28.6K
BPMP
9996
PUT
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$2K ﹤0.01%
3,200
-4,500
-58% -$78.5K
PBCT
9997
CALL
DELISTED
People's United Financial Inc
PBCT
$2K ﹤0.01%
5,400
-600
-10% -$12.3K
ORPH
9998
DELISTED
Orphazyme A/S
ORPH
$2K ﹤0.01%
3,484
-1,134
-25% -$1.89K
CONE
9999
CALL
DELISTED
CyrusOne Inc Common Stock
CONE
$2K ﹤0.01%
10,700
-17,300
-62% -$1.55M
ODT
10000
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$2K ﹤0.01%
2,000
-6,982
-78% -$8.76K

Similar funds

Simplex Trading's Q1 2022 Portfolio in Review

As of Q1 2022, Simplex Trading held 12,038 positions worth $109B, up 10% from $99B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Simplex Trading deployed $17.5B of net new capital in Q1 2022, opening 1,603 new positions and adding to 4,441 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 652,921 shares worth $86.2M.

By sector, the portfolio is most concentrated in Technology at 0.67% of assets, up from 0.61% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Verizon, an estimated $42.5M trimmed.

  • Simplex Trading's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 652,921 shares worth $86.2M.
  • Simplex Trading added most to Apple in Q1 2022, an estimated $179M increase.
  • Simplex Trading's biggest Q1 2022 reduction was Verizon, cutting an estimated $42.5M.
  • Simplex Trading fully exited State Street Financial Select Sector SPDR ETF in Q1 2022, selling an estimated $42.8M.
  • Simplex Trading's ten largest holdings make up 37% of its $109B portfolio in Q1 2022.
  • Simplex Trading opened 1,603 new positions and closed 1,637 in Q1 2022.
  • Simplex Trading's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Simplex Trading's 13F filing for Q1 2022, filed 2 May 2022.